Your Notifications
All done, no notifications

What is a Tricuspid Atresia?

Tricuspid Atresia is a congenital heart defect in which the tricuspid valve does not form, preventing normal blood flow from the right atrium to the right ventricle. The right ventricle is often underdeveloped, and babies usually have an opening between the atria, such as an atrial septal defect, to allow blood to reach the left side of the heart. Other defects, including a ventricular septal defect or patent ductus arteriosus, may also help maintain blood flow to the lungs; symptoms and treatment depend on the amount of pulmonary blood flow and associated heart abnormalities.

What is the Importance of Timely Treatment?

Timely treatment is critical in d-TGA because inadequate mixing of oxygenated and deoxygenated blood can cause severe oxygen deficiency soon after birth. Immediate stabilisation, maintenance or creation of adequate blood mixing, and definitive surgical repair can improve oxygen delivery and reduce the risk of serious complications. Lifelong congenital heart follow-up is also important after repair because some patients may develop valve, coronary artery, rhythm, or other cardiac problems later in life.

What are the Common Symptoms of Tricuspid Atresia?

  • Cyanosis: Bluish or greyish skin, lips, or nails may appear soon after birth because of low blood oxygen levels.
  • Breathing Difficulties: Rapid or difficult breathing may occur when the baby has inadequate oxygen delivery or associated heart problems.
  • Poor Feeding: Babies may have difficulty feeding, tire easily during feeds, or take longer to feed.
  • Weak Pulse: Reduced oxygen delivery and impaired circulation may contribute to weak pulses.
  • Rapid Heartbeat: A fast heartbeat may occur as the heart attempts to maintain adequate circulation.
  • Poor Weight Gain: Babies with significant congenital heart disease may have difficulty gaining weight and growing normally.

Causes and Risk Factors of Tricuspid Atresia

Causes

  • Abnormal Heart Development: TGA occurs because the major arteries do not develop with their normal connections to the ventricles during fetal heart development.
  • Genetic Factors: Genetic or chromosomal factors may contribute to some congenital heart defects, although the specific cause of d-TGA is unknown in most cases.
  • Developmental Factors: Complex interactions between genetic and environmental factors may influence heart development.

Risk Factors

  • Maternal Diabetes: Poorly controlled diabetes during pregnancy has been associated with an increased risk of d-TGA.
  • Family History: A family history of congenital heart defects may increase the likelihood of certain congenital cardiac abnormalities.
  • Genetic or Chromosomal Conditions: Some congenital heart defects occur as part of genetic or chromosomal conditions.
  • Pregnancy-Related Factors: Certain maternal health, environmental, medication, or nutritional factors may contribute to congenital heart defect risk, although most cases of d-TGA do not have an identifiable cause.

Latest Research and Technologies in the Treatment of Tricuspid Atresia in India

  • Current TGA care focuses on early prenatal and newborn diagnosis, rapid stabilisation, advanced echocardiography, specialised neonatal cardiac care, and timely surgical repair. Fetal echocardiography can help identify d-TGA before birth, while newborn pulse oximetry and postnatal echocardiography support diagnosis and assessment of associated defects and cardiac function. For d-TGA, the arterial switch operation (ASO) is the most commonly used definitive repair and is generally performed early in life. In critically cyanotic newborns, prostaglandin therapy may maintain ductal blood flow, while balloon atrial septostomy may improve blood mixing when necessary.

Treatment options for Tricuspid Atresia

Ductal Stenting: In selected babies, a stent may be placed in the ductus arteriosus to maintain pulmonary blood flow and reduce the need for an early surgical shunt.

Systemic-to-Pulmonary Artery Shunt: A surgical shunt may be created to increase blood flow to the lungs when the baby's anatomy requires additional pulmonary blood flow.

Balloon Atrial Septostomy (BAS) : A cardiologist performs a BAS (also known as a Rashkind procedure). They insert a thin, flexible tube called a catheter into a blood vessel, usually in the groin, and thread it up to the heart.


Cost Start From 4500Explore Options

Pulmonary Artery Banding: If too much blood is reaching the lungs, pulmonary artery banding may be used in selected patients to control pulmonary blood flow and protect the pulmonary circulation.

Bidirectional Glenn Operation : In this staged procedure, the superior vena cava is connected directly to the pulmonary arteries, allowing blood from the upper body to flow to the lungs without passing through the right ventricle.


Cost Start From 8000Explore Options

Fontan Procedure : The final major stage of palliation connects venous blood from the lower body to the pulmonary arteries, allowing blood to reach the lungs without ventricular pumping. Selected patients may undergo a fenestration.


Cost Start From 8000Explore Options

Heart Transplantation : Rarely, transplantation may be considered when the heart becomes severely weakened or when the Fontan circulation fails, and other treatments are unsuitable.


Cost Start From 46000Explore Options

  • Clinical assessment:
    • Prenatal Assessment: Routine pregnancy ultrasound may raise suspicion of tricuspid atresia, followed by fetal echocardiography for detailed assessment.
    • Medical and Birth History: Assessment includes pregnancy history, delivery details, cyanosis, breathing, feeding, and associated congenital conditions.
    • Physical Examination: Evaluation of skin colour, breathing, heart sounds, pulse, blood pressure, oxygen saturation, and signs of poor circulation.
    • Electrocardiogram (ECG): May provide information about heart rhythm and electrical activity.
    • Blood Tests: Blood gases, glucose, electrolytes, blood counts, and other tests may be used during neonatal stabilisation and treatment.
  • Imaging Tests:
    • Fetal Echocardiography: Provides detailed prenatal assessment of the heart chambers, valves, great arteries, septal defects, and blood flow.
    • Transthoracic Echocardiography (TTE): The primary postnatal imaging test used to confirm tricuspid atresia and assess ventricular size, associated defects, pulmonary blood flow, and cardiac function.
    • Chest X-Ray: May provide information about heart size and pulmonary blood flow.
    • Cardiac CT: May provide detailed anatomical information in selected complex cases or when additional anatomical assessment is required.
    • Cardiac MRI: Can assess ventricular function, pulmonary arteries, blood flow, and other structures during later childhood or adult follow-up.
    • Cardiac Catheterization: Measures pressures and oxygen levels within the heart and blood vessels and can also be used for selected interventions.
    • Three-Dimensional Imaging: Advanced imaging may assist detailed anatomical assessment and procedural planning in selected complex cases.

MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services designed to support Tricuspid Atresia patients in India. These services include:

  • Cardiac Rehabilitation: Selected children and adults may benefit from structured rehabilitation according to cardiac function and treatment history.
  • Gradual Physical Activity: Increase activity according to oxygen levels, ventricular function, symptoms, rhythm status, and congenital heart specialist advice.
  • Paediatric Developmental Support: Children with complex congenital heart disease may require developmental assessment and early supportive interventions.
  • Occupational Therapy: Selected children may benefit from support with age-appropriate functional activities and independence.
  • Exercise Assessment: Older children and adults may undergo exercise testing to guide safe physical activity.
  • Long-Term Congenital Heart Follow-Up: Regular specialist assessments help monitor ventricular function, oxygen levels, rhythm, Fontan circulation, liver health, exercise capacity, and other potential complications.
  • Medicines used in Tricuspid Atresia depend on the baby's anatomy, oxygen level, pulmonary blood flow, ventricular function, and treatment stage. Doctors may give prostaglandin E1 soon after birth to keep the duct open and support pulmonary blood flow. Other medicines may help manage heart failure, fluid retention, blood pressure, or abnormal heart rhythms. After staged surgery, some patients may require medicines such as diuretics, rhythm-control medicines, antiplatelet therapy, or anticoagulation depending on their circulation and individual risk.

Instantly Connect with our Specialists

Doctor 1
Doctor 2
Doctor 3
Doctor 4
Doctor 5
Doctor 6
Doctor 7
Doctor 8

Hospitals for Tricuspid Atresia in India

Manipal Hospital, Ghaziabad: Top Doctors, and Reviews
Manipal Hospital, Ghaziabad

Ghaziabad, India

Founded in 2010, Manipal Hospital-Ghaziabad (formerly Columbia Asia Hospital) is a well-known multispecialty hospital accredited by the National Accreditation Board for Hospitals and Healthcare Providers (NABH). With 100 beds, the hospital is committed to providing effective and reasonably priced healthcare in a clean and safe setting. The hospital has several departments that are known for their expertise, including Orthopaedics, Internal Medicine, Gastroenterology, Plastic Surgery, Obstetrics and Gynecology, ENT, and more. Due to this recognition, the hospital is now regarded as one of the best medical establishments in the Ghaziabad area.

Message Us
Rajagiri Hospital: Top Doctors, and Reviews
Rajagiri Hospital

Kochi, India

  • Rajagiri Hospital, Kochi, Kerala, is a leading multi-speciality tertiary care hospital known for providing world-class medical services with advanced technology and compassionate care.
  • Accredited by JCI, NABH, and NABL, the hospital offers comprehensive treatment across specialities like Cardiology, Oncology, Neurology, Gastroenterology, Orthopaedics, Nephrology, Urology, and Paediatrics, making it a trusted healthcare destination in South India.
Message Us
Gleneagles Hospital Mumbai: Top Doctors, and Reviews
Gleneagles Hospital Mumbai

Mumbai, India

  • Gleneagles Hospital, Parel, Mumbai, is a premier quaternary-care multispeciality hospital and a top destination for complex medical care in Western India.
  • Renowned for multi-organ transplants and advanced surgeries, the hospital offers specialised treatment across Cardiology, Neurology, Gastroenterology, Hepatology, Nephrology, Urology, Orthopaedics, Critical Care, Interventional Radiology, Gynaecology, and General Medicine.
  • Equipped with state-of-the-art diagnostic and surgical technology, including 3-Tesla MRI, 128-slice CT Scan, Bi-plane Cath Lab, and robotic surgery systems, Gleneagles provides integrated, patient-focused care.
  • Its expert team of doctors, nurses, and support staff ensures high standards of safety, efficiency, and compassionate care, making it a trusted healthcare destination for patients in Mumbai and beyond.
Message Us

Our Services to better your experience

Opinion & Option

We submit the most accurate opinion and options from one or more countries for your review

Consult Privately

Consult with a certified specialist privately on our telemedicine platform even before you decide to travel

Logistics

We handle flights, visas, transfers, and accommodation—so you can focus on your health.

Recovery

Our In-house rehabilitation service packages to better your recovery and treatment outcome

Why Choose India for Tricuspid Atresia Treatment?

  • Experienced Paediatric Cardiac Specialists: Access to paediatric cardiologists, congenital heart surgeons, cardiac intensivists, and specialists experienced in complex congenital heart disease.
  • Advanced Newborn Cardiac Care: Specialised centres may provide neonatal intensive care, continuous monitoring, respiratory support, and urgent cardiovascular stabilisation.
  • Advanced Echocardiography: Fetal and postnatal echocardiography can support early diagnosis and treatment planning.
  • Cardiac Catheterisation Facilities: Eligible patients may have access to ductal stenting, diagnostic catheterisation, and other catheter-based procedures.
  • Staged Congenital Heart Surgery: Specialised centres can perform systemic-to-pulmonary shunts, Glenn procedures, Fontan procedures, and surgery for associated defects.
  • Multidisciplinary Heart Teams: Paediatric cardiologists, cardiac surgeons, intensivists, anaesthesiologists, imaging specialists, nurses, nutritionists, and rehabilitation professionals can coordinate complex care.
  • Long-Term Congenital Heart Follow-Up: Specialist programmes can monitor patients from childhood into adulthood for Fontan-related complications, arrhythmias, ventricular function, and exercise capacity.
  • International Patient Support: Many major Indian hospitals assist international patients with medical records, appointments, treatment coordination, accommodation, and follow-up.

Frequently Asked Questions

Tricuspid atresia usually requires staged treatment rather than a single procedure. Hospital recovery varies after each procedure, and the overall treatment pathway may extend through infancy and early childhood. Lifelong cardiac follow-up is required because the surgical procedures improve circulation but do not cure the underlying congenital heart defect.

A newborn with untreated tricuspid atresia may have critically low oxygen levels and requires urgent medical treatment rather than routine physical activity. After staged treatment, many children and adults can walk and remain active, but activity should be individualised according to oxygen saturation, ventricular function, heart rhythm, Fontan circulation, and specialist advice.

Many advanced Indian paediatric cardiac centres provide fetal and postnatal echocardiography, neonatal intensive care, cardiac catheterisation, ductal interventions, surgical shunts, Glenn and Fontan procedures, advanced cardiac imaging, and long-term congenital-heart follow-up.

Many major Indian hospitals have international patient departments that assist overseas families with medical records, appointments, treatment coordination, accommodation, interpretation where available, and follow-up arrangements. However, critically ill newborns require immediate local stabilisation and should not have urgent treatment delayed for international travel.

Look for a centre with paediatric cardiologists, congenital-heart surgeons, neonatal cardiac intensive care, advanced echocardiography, cardiac catheterisation facilities, and experience with staged single-ventricle procedures such as the Glenn and Fontan operations. Access to lifelong congenital heart follow-up is also important.

No single success rate applies to all patients. Outcomes depend on the baby's anatomy, pulmonary blood flow, ventricular function, associated heart defects, oxygen levels, surgical stage, and postoperative complications. The treating congenital heart team can discuss expected outcomes based on the individual clinical condition

Many specialised Indian paediatric cardiac centres have multidisciplinary teams experienced in managing complex congenital heart conditions, including neonatal stabilisation, catheter-based procedures, staged surgical palliation, postoperative intensive care, and long-term congenital-heart follow-up.

Risks depend on the patient's condition and the procedure performed. Catheter-based procedures may involve bleeding, blood-vessel injury, infection, arrhythmias, or other complications. Surgical procedures may involve bleeding, infection, rhythm disturbances, blood clots, neurological complications, organ dysfunction, or problems with the surgical circulation.

Tricuspid atresia is a congenital heart condition, not an injury. If a newborn develops blue or grey skin, breathing difficulty, poor feeding, extreme sleepiness, or other signs of low oxygen, seek emergency medical care immediately. Tricuspid atresia is a critical congenital heart defect that may require urgent stabilisation and treatment soon after birth.

Tricuspid atresia does not directly cause physical or skeletal deformities. However, the condition and staged surgeries can be associated with long-term cardiac complications that may affect exercise capacity, development, or physical functioning. Lifelong congenital heart follow-up is important.

Yes. Tricuspid atresia and its treatment can affect exercise capacity, oxygen levels, daily activities, development, and overall well-being. Many people who undergo successful staged treatment can live active and productive lives, although ongoing medical care and individual activity guidance may be necessary.

Yes. Untreated tricuspid atresia can cause severe low oxygen levels, inadequate blood flow to the lungs and body, heart failure, and potentially life-threatening complications. Even after surgical treatment, patients require lifelong monitoring because arrhythmias, ventricular dysfunction, blood clots, fluid retention, and other complications may develop over time.

Tricuspid atresia develops during fetal heart formation and generally cannot be prevented. The exact cause is unknown in most cases. Appropriate prenatal care and management of maternal health conditions can support overall pregnancy health, while prenatal screening and fetal echocardiography may help identify the condition early.

Tricuspid atresia can occur in any pregnancy and most cases do not have a clearly identifiable cause. Some congenital heart defects may be associated with genetic or chromosomal factors, but most babies with tricuspid atresia do not have a known preventable risk factor.